Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

NKTR US Equity

Nektar TherapeuticsHealth Care · Pharmaceutical Preparations · CIK 906709 · FY ends Dec 31
$76.08
+2.44 (+3.31%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Two Seas Capital LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-29

Every row is a filed document, checked against its EDGAR index.